Clancy Paul J — SEC insider filings

SEC reporting owner CIK 1409601. 53 insider filings on record with FilingPulse; latest filed 2026-11-19.

Transaction summary — filings shown

Covers the 50 most recent of 53 filings on record, filed 2021-04-01 to 2026-11-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
INCYTE CORP (INCY)Director30—1 leg · 15,000 sh · $1,423,95037
AGIOS PHARMACEUTICALS, INC. (AGIO)Director4——8
EXACT SCIENCES CORP (EXAS)Director7——8
Xilio Therapeutics, Inc. (XLO)Director5——6
Sionna Therapeutics, Inc. (SION)Director2——2
ALIGN TECHNOLOGY INC (ALGN)Director2——1

Insider filings — Clancy Paul J

FiledFormIssuerReported transactionsSource
2026-11-193ALIGN TECHNOLOGY INC (ALGN)Holdings only — no transactions reportedEDGAR
2026-11-194ALIGN TECHNOLOGY INC (ALGN)Grant/award (A): 903 (derivative) @ $0EDGAR
2026-10-024INCYTE CORP (INCY)Grant/award (A): 203 @ $121.35EDGAR
2026-07-024INCYTE CORP (INCY)Grant/award (A): 252 @ $113.36EDGAR
2026-06-184Sionna Therapeutics, Inc. (SION)Grant/award (A): 17,340 (derivative) @ $0EDGAR
2026-06-104INCYTE CORP (INCY)Grant/award (A): 1,642 @ $0 · Grant/award (A): 6,111 (derivative) @ $0EDGAR
2026-05-214INCYTE CORP (INCY)Option exercise (M): 15,000 @ $84.53 · Sale (S): 15,000 @ $94.93 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2026-04-024INCYTE CORP (INCY)Grant/award (A): 265 @ $94.12EDGAR
2026-03-234EXACT SCIENCES CORP (EXAS)Disposition to issuer (D): 20,640 · Disposition to issuer (D): 5,398EDGAR
2026-01-054INCYTE CORP (INCY)Grant/award (A): 241 @ $98.77EDGAR
2025-10-024INCYTE CORP (INCY)Grant/award (A): 285 @ $84.81EDGAR
2025-07-024INCYTE CORP (INCY)Grant/award (A): 361 @ $68.10EDGAR
2025-06-164EXACT SCIENCES CORP (EXAS)Grant/award (A): 5,398 @ $0EDGAR
2025-06-164Sionna Therapeutics, Inc. (SION)Grant/award (A): 19,959 (derivative) @ $0EDGAR
2025-06-124Xilio Therapeutics, Inc. (XLO)Grant/award (A): 31,000 (derivative) @ $0EDGAR
2025-06-124INCYTE CORP (INCY)Grant/award (A): 2,518 @ $0 · Grant/award (A): 9,216 (derivative) @ $0EDGAR
2025-04-024INCYTE CORP (INCY)Grant/award (A): 358 @ $60.55EDGAR
2025-01-034INCYTE CORP (INCY)Grant/award (A): 331 @ $69.07EDGAR
2024-12-204/AEXACT SCIENCES CORP (EXAS)Grant/award (A): 5,939 @ $0EDGAR
2024-10-024INCYTE CORP (INCY)Grant/award (A): 368 @ $66.10EDGAR
2024-07-024INCYTE CORP (INCY)Grant/award (A): 399 @ $60.62EDGAR
2024-06-174EXACT SCIENCES CORP (EXAS)Grant/award (A): 5,444 @ $0EDGAR
2024-06-174Xilio Therapeutics, Inc. (XLO)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2024-06-144INCYTE CORP (INCY)Grant/award (A): 2,830 @ $0 · Grant/award (A): 12,517 (derivative) @ $0EDGAR
2024-04-024INCYTE CORP (INCY)Grant/award (A): 403 @ $56.97EDGAR
2024-01-034INCYTE CORP (INCY)Grant/award (A): 412 @ $62.79EDGAR
2023-10-034INCYTE CORP (INCY)Grant/award (A): 379 @ $57.77EDGAR
2023-07-054INCYTE CORP (INCY)Grant/award (A): 380 @ $62.25EDGAR
2023-06-164INCYTE CORP (INCY)Grant/award (A): 2,505 @ $0 · Grant/award (A): 11,294 (derivative) @ $0EDGAR
2023-06-134Xilio Therapeutics, Inc. (XLO)Grant/award (A): 13,200 (derivative) @ $0EDGAR
2023-06-124EXACT SCIENCES CORP (EXAS)Grant/award (A): 3,599 @ $0EDGAR
2023-04-044INCYTE CORP (INCY)Grant/award (A): 318 @ $72.27EDGAR
2023-01-044INCYTE CORP (INCY)Grant/award (A): 294 @ $80.32EDGAR
2022-10-044INCYTE CORP (INCY)Grant/award (A): 339 @ $66.64EDGAR
2022-07-014INCYTE CORP (INCY)Grant/award (A): 321 @ $75.97EDGAR
2022-06-234AGIOS PHARMACEUTICALS, INC. (AGIO)Grant/award (A): 4,975 (derivative) @ $0 · Grant/award (A): 29,307 (derivative) @ $0EDGAR
2022-06-174INCYTE CORP (INCY)Grant/award (A): 2,144 @ $0 · Grant/award (A): 9,124 (derivative) @ $0EDGAR
2022-06-174Xilio Therapeutics, Inc. (XLO)Grant/award (A): 13,200 (derivative) @ $0EDGAR
2022-06-134EXACT SCIENCES CORP (EXAS)Grant/award (A): 5,606 @ $0EDGAR
2022-05-244AGIOS PHARMACEUTICALS, INC. (AGIO)Option exercise (M): 1,585 @ $0 · Option exercise (M): 1,585 (derivative) @ $0EDGAR
2022-04-044INCYTE CORP (INCY)Grant/award (A): 326 @ $79.42EDGAR
2022-01-044INCYTE CORP (INCY)Grant/award (A): 343 @ $73.40EDGAR
2021-10-264Xilio Therapeutics, Inc. (XLO)Grant/award (A): 44,033 (derivative) @ $0 · Grant/award (A): 65,528 (derivative) @ $0EDGAR
2021-10-044INCYTE CORP (INCY)Grant/award (A): 321 @ $68.78EDGAR
2021-07-024EXACT SCIENCES CORP (EXAS)Grant/award (A): 2,567 @ $0EDGAR
2021-07-024INCYTE CORP (INCY)Grant/award (A): 283 @ $84.13EDGAR
2021-06-024AGIOS PHARMACEUTICALS, INC. (AGIO)Option exercise (M): 1,686 @ $0 · Option exercise (M): 1,686 (derivative) @ $0EDGAR
2021-05-284INCYTE CORP (INCY)Grant/award (A): 1,923 @ $0 · Grant/award (A): 8,010 (derivative) @ $0EDGAR
2021-05-244AGIOS PHARMACEUTICALS, INC. (AGIO)Grant/award (A): 1,585 (derivative) @ $0 · Grant/award (A): 8,888 (derivative) @ $0EDGAR
2021-04-014INCYTE CORP (INCY)Grant/award (A): 298 @ $81.27EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1409601 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs